Free Trial

Colgate-Palmolive (NYSE:CL) Shares Acquired by Intech Investment Management LLC

Colgate-Palmolive logo with Consumer Staples background

Intech Investment Management LLC grew its position in Colgate-Palmolive (NYSE:CL - Free Report) by 48.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 132,417 shares of the company's stock after purchasing an additional 43,481 shares during the period. Intech Investment Management LLC's holdings in Colgate-Palmolive were worth $13,746,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Cornerstone Advisors LLC boosted its stake in Colgate-Palmolive by 8.8% during the third quarter. Cornerstone Advisors LLC now owns 40,931 shares of the company's stock valued at $4,249,000 after buying an additional 3,300 shares during the period. Moran Wealth Management LLC raised its stake in Colgate-Palmolive by 53.1% in the third quarter. Moran Wealth Management LLC now owns 7,738 shares of the company's stock valued at $803,000 after purchasing an additional 2,684 shares in the last quarter. EagleClaw Capital Managment LLC lifted its position in Colgate-Palmolive by 0.9% during the third quarter. EagleClaw Capital Managment LLC now owns 32,879 shares of the company's stock valued at $3,413,000 after purchasing an additional 300 shares during the last quarter. First Horizon Advisors Inc. grew its stake in Colgate-Palmolive by 13.7% in the 3rd quarter. First Horizon Advisors Inc. now owns 17,132 shares of the company's stock worth $1,779,000 after buying an additional 2,064 shares in the last quarter. Finally, Advisors Asset Management Inc. increased its holdings in shares of Colgate-Palmolive by 35.0% in the 3rd quarter. Advisors Asset Management Inc. now owns 64,264 shares of the company's stock worth $6,671,000 after buying an additional 16,661 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business's stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company's stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 0.34% of the company's stock.

Analyst Ratings Changes

A number of brokerages have commented on CL. Morgan Stanley increased their price target on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the company an "overweight" rating in a research report on Monday, July 29th. Barclays raised their target price on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the stock an "equal weight" rating in a report on Monday, July 29th. Hsbc Global Res cut shares of Colgate-Palmolive from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 26th. Sanford C. Bernstein boosted their price objective on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the company a "market perform" rating in a research report on Tuesday, July 30th. Finally, StockNews.com raised Colgate-Palmolive from a "hold" rating to a "buy" rating in a research note on Thursday, November 14th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $105.11.

View Our Latest Analysis on CL

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock traded up $0.66 during trading hours on Friday, reaching $94.91. 3,538,918 shares of the company's stock were exchanged, compared to its average volume of 4,383,245. Colgate-Palmolive has a 1 year low of $75.50 and a 1 year high of $109.30. The company has a market capitalization of $77.54 billion, a P/E ratio of 27.04, a price-to-earnings-growth ratio of 3.34 and a beta of 0.42. The business has a fifty day moving average of $98.32 and a two-hundred day moving average of $98.50. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.11%. The ex-dividend date was Friday, October 18th. Colgate-Palmolive's dividend payout ratio is currently 57.31%.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Should you invest $1,000 in Colgate-Palmolive right now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines